Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients

Marie A. Chisholm, Laura L Mulloy, Muralidharan Jagadeesan, Bradley C. Martin, Joseph T. DiPiro

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: The objective of this study was to determine if African-American renal transplant patients who received direct patient care from a clinical pharmacist had better blood pressure control compared to African-American renal transplant patients who did not have clinical pharmacy services. Methods: Renal transplant patients were prospectively randomized into an intervention group or a control group. Patients in the intervention group received clinical pharmacy services that included a clinical pharmacist performing patient medication reviews, with emphasis on preventing or resolving medication-related problems and providing medication recommendations. Patients in the control group received routine clinic services, but had no clinical pharmacist interaction. Analysis was performed to detect differences between the intervention and control groups in baseline and quarterly systolic blood pressure (SBP) and diastolic blood pressure (DBP) for one year post-study enrollment. Results: There were no differences between the intervention (N = 13) and control (N = 10) groups in baseline blood pressures or in the percentage of hypertensive patients. Significant differences in the change in SBP and DBP from baseline between the intervention and control groups were observed at the second, third, and fourth quarters of the study, favoring the intervention group (P <.01). Mean SBP was significantly lower in the intervention group at the second (137.8 ± 15.0 vs 168.9 ± 15.3), third (135.9 ± 11.7 vs 164.6 ± 20.1), and fourth (145.3 ± 16.8 vs 175.8 ± 33.9) quarters of the study (P < .05). Mean DBP was significantly lower in the intervention group at the second (76.0 ± 11.8 vs 84.9 ± 6.1) and fourth (77.0 ± 10.2 vs 91.8 ± 12.0) quarters (P <.05). Conclusion: Direct patient care services provided by a clinical pharmacist, in addition to routine clinical services, have a positive effect on the blood pressure of African-American renal transplant patients. A multidisciplinary team that includes a clinical pharmacist is beneficial to patient care.

Original languageEnglish (US)
Pages (from-to)392-397
Number of pages6
JournalEthnicity and Disease
Volume12
Issue number3
StatePublished - Aug 27 2002

Fingerprint

Hospital Pharmacy Services
African Americans
Blood Pressure
Transplants
Kidney
Pharmacists
Patient Care
Control Groups

Keywords

  • Clinical pharmacy services
  • Hypertensive African-American patients
  • Hypertensive renal transplant patients

ASJC Scopus subject areas

  • Epidemiology

Cite this

Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. / Chisholm, Marie A.; Mulloy, Laura L; Jagadeesan, Muralidharan; Martin, Bradley C.; DiPiro, Joseph T.

In: Ethnicity and Disease, Vol. 12, No. 3, 27.08.2002, p. 392-397.

Research output: Contribution to journalArticle

Chisholm, MA, Mulloy, LL, Jagadeesan, M, Martin, BC & DiPiro, JT 2002, 'Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients', Ethnicity and Disease, vol. 12, no. 3, pp. 392-397.
Chisholm, Marie A. ; Mulloy, Laura L ; Jagadeesan, Muralidharan ; Martin, Bradley C. ; DiPiro, Joseph T. / Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. In: Ethnicity and Disease. 2002 ; Vol. 12, No. 3. pp. 392-397.
@article{b71ac0b5648d441b8e45cd75a3f46ecb,
title = "Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients",
abstract = "Objective: The objective of this study was to determine if African-American renal transplant patients who received direct patient care from a clinical pharmacist had better blood pressure control compared to African-American renal transplant patients who did not have clinical pharmacy services. Methods: Renal transplant patients were prospectively randomized into an intervention group or a control group. Patients in the intervention group received clinical pharmacy services that included a clinical pharmacist performing patient medication reviews, with emphasis on preventing or resolving medication-related problems and providing medication recommendations. Patients in the control group received routine clinic services, but had no clinical pharmacist interaction. Analysis was performed to detect differences between the intervention and control groups in baseline and quarterly systolic blood pressure (SBP) and diastolic blood pressure (DBP) for one year post-study enrollment. Results: There were no differences between the intervention (N = 13) and control (N = 10) groups in baseline blood pressures or in the percentage of hypertensive patients. Significant differences in the change in SBP and DBP from baseline between the intervention and control groups were observed at the second, third, and fourth quarters of the study, favoring the intervention group (P <.01). Mean SBP was significantly lower in the intervention group at the second (137.8 ± 15.0 vs 168.9 ± 15.3), third (135.9 ± 11.7 vs 164.6 ± 20.1), and fourth (145.3 ± 16.8 vs 175.8 ± 33.9) quarters of the study (P < .05). Mean DBP was significantly lower in the intervention group at the second (76.0 ± 11.8 vs 84.9 ± 6.1) and fourth (77.0 ± 10.2 vs 91.8 ± 12.0) quarters (P <.05). Conclusion: Direct patient care services provided by a clinical pharmacist, in addition to routine clinical services, have a positive effect on the blood pressure of African-American renal transplant patients. A multidisciplinary team that includes a clinical pharmacist is beneficial to patient care.",
keywords = "Clinical pharmacy services, Hypertensive African-American patients, Hypertensive renal transplant patients",
author = "Chisholm, {Marie A.} and Mulloy, {Laura L} and Muralidharan Jagadeesan and Martin, {Bradley C.} and DiPiro, {Joseph T.}",
year = "2002",
month = "8",
day = "27",
language = "English (US)",
volume = "12",
pages = "392--397",
journal = "Ethnicity and Disease",
issn = "1049-510X",
publisher = "ISHIB",
number = "3",

}

TY - JOUR

T1 - Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients

AU - Chisholm, Marie A.

AU - Mulloy, Laura L

AU - Jagadeesan, Muralidharan

AU - Martin, Bradley C.

AU - DiPiro, Joseph T.

PY - 2002/8/27

Y1 - 2002/8/27

N2 - Objective: The objective of this study was to determine if African-American renal transplant patients who received direct patient care from a clinical pharmacist had better blood pressure control compared to African-American renal transplant patients who did not have clinical pharmacy services. Methods: Renal transplant patients were prospectively randomized into an intervention group or a control group. Patients in the intervention group received clinical pharmacy services that included a clinical pharmacist performing patient medication reviews, with emphasis on preventing or resolving medication-related problems and providing medication recommendations. Patients in the control group received routine clinic services, but had no clinical pharmacist interaction. Analysis was performed to detect differences between the intervention and control groups in baseline and quarterly systolic blood pressure (SBP) and diastolic blood pressure (DBP) for one year post-study enrollment. Results: There were no differences between the intervention (N = 13) and control (N = 10) groups in baseline blood pressures or in the percentage of hypertensive patients. Significant differences in the change in SBP and DBP from baseline between the intervention and control groups were observed at the second, third, and fourth quarters of the study, favoring the intervention group (P <.01). Mean SBP was significantly lower in the intervention group at the second (137.8 ± 15.0 vs 168.9 ± 15.3), third (135.9 ± 11.7 vs 164.6 ± 20.1), and fourth (145.3 ± 16.8 vs 175.8 ± 33.9) quarters of the study (P < .05). Mean DBP was significantly lower in the intervention group at the second (76.0 ± 11.8 vs 84.9 ± 6.1) and fourth (77.0 ± 10.2 vs 91.8 ± 12.0) quarters (P <.05). Conclusion: Direct patient care services provided by a clinical pharmacist, in addition to routine clinical services, have a positive effect on the blood pressure of African-American renal transplant patients. A multidisciplinary team that includes a clinical pharmacist is beneficial to patient care.

AB - Objective: The objective of this study was to determine if African-American renal transplant patients who received direct patient care from a clinical pharmacist had better blood pressure control compared to African-American renal transplant patients who did not have clinical pharmacy services. Methods: Renal transplant patients were prospectively randomized into an intervention group or a control group. Patients in the intervention group received clinical pharmacy services that included a clinical pharmacist performing patient medication reviews, with emphasis on preventing or resolving medication-related problems and providing medication recommendations. Patients in the control group received routine clinic services, but had no clinical pharmacist interaction. Analysis was performed to detect differences between the intervention and control groups in baseline and quarterly systolic blood pressure (SBP) and diastolic blood pressure (DBP) for one year post-study enrollment. Results: There were no differences between the intervention (N = 13) and control (N = 10) groups in baseline blood pressures or in the percentage of hypertensive patients. Significant differences in the change in SBP and DBP from baseline between the intervention and control groups were observed at the second, third, and fourth quarters of the study, favoring the intervention group (P <.01). Mean SBP was significantly lower in the intervention group at the second (137.8 ± 15.0 vs 168.9 ± 15.3), third (135.9 ± 11.7 vs 164.6 ± 20.1), and fourth (145.3 ± 16.8 vs 175.8 ± 33.9) quarters of the study (P < .05). Mean DBP was significantly lower in the intervention group at the second (76.0 ± 11.8 vs 84.9 ± 6.1) and fourth (77.0 ± 10.2 vs 91.8 ± 12.0) quarters (P <.05). Conclusion: Direct patient care services provided by a clinical pharmacist, in addition to routine clinical services, have a positive effect on the blood pressure of African-American renal transplant patients. A multidisciplinary team that includes a clinical pharmacist is beneficial to patient care.

KW - Clinical pharmacy services

KW - Hypertensive African-American patients

KW - Hypertensive renal transplant patients

UR - http://www.scopus.com/inward/record.url?scp=0035987638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035987638&partnerID=8YFLogxK

M3 - Article

C2 - 12148711

AN - SCOPUS:0035987638

VL - 12

SP - 392

EP - 397

JO - Ethnicity and Disease

JF - Ethnicity and Disease

SN - 1049-510X

IS - 3

ER -